Bachem is excited to announce that the company has been recognized as one of the five winners of the Swiss Biotech Success Stories Awards 2021.
The awards, bestowed by the Swiss Biotech Association, celebrates those who have made important and sustainable contributions to the biotech industry in Switzerland.
Bachem is a world leader in the manufacturing of peptides and is expanding into oligonucleotides – both are highly complex drug substances that are increasingly used in modern medicine. The company was founded in Switzerland and has sites in Vionnaz and Bubendorf, as well as sites in the UK, the US and an office in Japan.
“I am happy that Bachem has won a Swiss Biotech Success Stories Award. Within fifty years, we have grown from a small company of two people to a leading provider for the world’s biopharmaceutical industry. This award is a testament to the team of talented and dedicated people that are the foundation of Bachem’s long-term success. I would like to thank the Swiss Biotech Association for this recognition.
We are proud of our strong Swiss heritage as we are of the strong global impact we can make for our customers and ultimately patients worldwide.
At Bachem, we take a long-term approach and continue to see broad-based growth, both in terms of products and geography. Despite the challenges of the ongoing COVID-19 pandemic, we continue to build new production capabilities and hire people across all our sites.”
“The tag for our initiative is Success Stories, but what we really mean is Value! Bachem is an entrepreneurial story that consistently created value for the last 50 years in Switzerland and abroad. Like with the current laureates and the one to come, it is important to celebrate valuable achievements within the life sciences ecosystem but it is also essential to share it with the public to educate, and the young generations as a palatable path forward for their future.”
Bachem was chosen as a winner due to a number of success categories, including:
- Completed achievement with lasting impact
- Creation of jobs in Switzerland
- Enabler for the biotech industry
- Involvement of one or more Swiss citizens
- Product approval and sustainable revenues
- Swiss-based company / institution
- Swissness: Think global, made in Switzerland
impressions from swiss biotech day 2021
The Swiss Biotech Day 2021 took place on Tuesday, September 7, 2021.
It was a great event, where senior experts and delegations from the life science industry from across Europe came together.
The award ceremony for the Swiss Biotech Success Stories took place during this event. Bachem is grateful and proud that its Bachem Success Story received an award for its sustainable contributions to the Swiss biotech industry.
It was also nice to have Thomas Meier participate in a highly interesting panel discussion with other colleagues from the biochemical industry on the state of pharmaceutical production in Switzerland.
About the Swiss Biotech Association
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss Biotech™.
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Subscribe to our newsletter
"*" indicates required fields